In the news | 1st March 2017
Disruptive Technologies
PharmaVoice.com
Scott Weiss, Vice President of Product Strategy, contributes his insight to PharmaVOICE’s Disruptive Technologies issue, sharing his knowledge and thoughts on fuelling innovation and transforming the industry for the future. Read his commentary on pages 18 & 20.
More news
How to get more insight and value out of your Electronic Batch Record data with PIMS
Discover how PIMS can work synergistically with your existing Electronic Batch Record (EBR) software and why PIMS is a great alternative.
New process definition capabilities in PIMS further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Tradeshow | European BioAnalysis Forum | Nov 2023
Speak to our experts to learn how an innovative approach to transform your bioanalytical operations and to improve data quality, productivity and compliance, according to industry standards such as ICH M10 standards
Software validation keeps GxP systems current and speeds up time-to-market
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.